Many Cell & Gene therapies have been developed, but this field still needs further research. Our wide range of products are here to help. Have a look!
How AllCells’ Expanded Donor Collection Facilities Help You to Recruit the Right Donors and Scale Your Cell and Gene Therapy Development
AllCells’ has thousands of well-characterised, highly engaged recallable donors, with specific attributes, at collection sites across the US & Europe.
Overcoming the Donor Selection Challenges to Drive Success in Cell and Gene Therapy Development and Commercialisation
AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.
DNA Transfection Reagents for Gene Expression
OZ Biosciences produces DNA transfection reagents for gene expression, for use with specific cells, cell lines or primary and difficult to transfect cells.
Netrin-1 – Neuron Guidance Factor Involved in iPS Regulation and Tumourigenesis
AdipoGen Life Sciences is the developer and manufacturer of the recombinant antibody clone 2F5 and biologically active human Netrin-1.
Apoptosis – Roadway to Pathogenesis and Treatment
MBL International offers antibodies, recombinant proteins, kits and assays to assist in the detection and analysis of different apoptotic molecules.
Rapid and Reliable Custom Tetramer Generation for T-Cell Staining
MBLI QuickSwitch™ kit technology aims to replicate the immune response by mimicking peptide exchange on an MHC molecule.
Protective Role of Invariant Natural Killer T (iNKT) cells
CD1d, non-classical MHC molecules, present phospholipid & glycosphingolipid antigens to iNKT cells. MBL tetramers help measure CD1d positive NKT cells
Generate bladder 2D/3D models with long-term cell line HBLAK for advanced urological research
CELLnTec provides HBLAK, which has become a more conveniently available model for urological research than primary urothelial cultures.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.